RxDoctor Payments Data

Kevin Ko, MD

Anesthesiology · New Brunswick, NJNPI 1174972129

Payments from drug & device makers

What this record shows

This record is dominated by travel and lodging: $8,590 of the $13,370 with a category attached, or 64.3%. Abbott accounts for 75.9% of it on its own, with 12 other manufacturers making up the rest. Reporting peaked in 2023 at $6,275 and has fallen 93.4% since, to $416 in 2025. Among anesthesiology clinicians in NJ with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$13,370in general payments, 2019–2025

Across 110 payments — averaging $121.54 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Abbott$10K
  • Medtronic$1K
  • Nevro Corp.$507
  • Relievant Medsystems, Inc.$375
  • Boston Scientific$274
  • Vertos Medical, Inc.$207
  • plus $427 from 7 others

What the payments were for

  • Travel & lodging$8,59064%
  • Food & beverage$4,78036%

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$13,370 in reported general payments places this provider in the 95th percentile of 1,430 anesthesiology providers in New Jersey.

See all anesthesiology providers in New Jersey

Medicare billing

Part B allowed, 2024
$27,007
Medicare patients
19
Services billed
1,407

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Celecoxib19$576
Pregabalin20$160
Tizanidine Hcl22$95

Paid to pharmacies, not to this prescriber.

Other anesthesiology in New Brunswick

See the full list for New Jersey

Where these figures come from

Is this you, or does something look wrong? →